PMCB: PharmaCyte Biotech, Inc. Stock

by  •  • Comments Off on PMCB: PharmaCyte Biotech, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 10.73
Enterprise Value ($M) -4.78
Book Value ($M) 43.45
Book Value / Share 6.24
Price / Book 0.25
NCAV ($M) 9.69
NCAV / Share 1.39
Price / NCAV 1.11

Profitability (mra)
Return on Invested Capital (ROIC) 0.52
Return on Assets (ROA) 0.32
Return on Equity (ROE) 0.42

Liquidity (mrq)
Quick Ratio 4.47
Current Ratio 4.47

Balance Sheet (mrq) ($M)
Current Assets 21.33
Assets 55.10
Liabilities 11.65
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
01-15 13G/A Intracoastal Capital, Llc
02-14 13G Ayrton Capital LLC 9.90 -45.38

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-12-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-09-17 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2024-03-18 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-05 4,103 34,070 12.04
2025-02-04 3,152 9,928 31.75
2025-02-03 1,696 11,996 14.14
2025-01-31 632 11,149 5.67

(click for more detail)

Similar Companies
PDSB – PDS Biotechnology Corporation PHIO – Phio Pharmaceuticals Corp.
PLUR – Pluri Inc. PMN – ProMIS Neurosciences, Inc.
PRFX – PainReform Ltd.


Financial data and stock pages provided by
Fintel.io